Monday 01 December 2025
Internal Reference Number: FOI_8870
Date Request Received: 21/08/2025 00:00:00
Date Request Replied To: 03/09/2025 00:00:00
This response was sent via: By Email
Request Summary: New Asthma Prescribing
Request Category: Researcher
| Question Number 1: I would like to raise an FOI request, with which I hope you will be able to help me with. How many new patients were treated for Asthma by the Trusts Respiratory Department in the latest 4 month period (April - July 2025) with the treatments I have provided below? Please can you define a "new patient" as a patient who has received any of the treatments listed below for the first time. If a patient received any of the below treatments before the 1st April 2024, they can be classed as a new patient for the purposes of this question. • Cinqaero (Reslizumab) • Dupixent (Dupilumab) • Fasenra (Benralizumab) • Nucala (Mepolizumab) • Tezpire (Tezepelumab) • Xolair (Omalizumab) | |
| Answer To Question 1: 6 patients treated with Omalizumab in the time period specified. No other results. | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
